Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

NCT00621244

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center/University of Texas Houston, Texas, United States
  • Novartis Investigative Site Parkville, Victoria, Australia
View Trial Details
Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

NCT02392611

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Scottsdale, Arizona, United States
  • Fort Wayne, Indiana, United States
  • Goshen, Indiana, United States
  • San Antonio, Texas, United States
View Trial Details
Completed

A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02729896

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • UCLA Los Angeles, California, United States
  • University Miami Miami, Florida, United States
  • Stony Brook University Hospital Stony Brook, New York, United States
  • Columbia Basin Hem-Onc; Department Hematology Oncology Kennewick, Washington, United States
View all 19 locations
View Trial Details
Completed

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.

NCT01237236

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering MSKCC (2) New York, United States
  • Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States
View Trial Details

Related conditions